DeepMed Research

Yonsei University

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 1885-01-01

Employees: 5K

Market Cap: -

Website: http://www.yonsei.ac.kr

Clinical Trials

The Association of Cardiac Ion Channel Related Gene Polymorphism and Prolonged QTc Interval After Endotracheal Intubation

Completed

Conditions: Emergence Delirium

First Posted Date: 2018-12-27

Last Posted Date: 2020-09-29

Lead Sponsor: Yonsei University

Target Recruit Count: 315

Registration Number: NCT03788564

Locations: 🇰🇷
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine, Seoul, Korea, Republic of

Study to Evaluate Efficacy of PDR001 in Patients With Squamous Cell Carcinoma of the Esophagus

Phase 2

Conditions: Histologically Confirmed Unresectable or Metastatic Squamous Cell Carcinoma of the Esophagus Who Failed on Standard Treatment

Interventions: Drug: PDR001

First Posted Date: 2018-12-24

Last Posted Date: 2021-05-06

Lead Sponsor: Yonsei University

Target Recruit Count: 44

Registration Number: NCT03785496

Locations: 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of

Comparisons of Novel Double-lumen Endobronchial Tube for Blind Lung Isolation Technique With Conventional Double-lumen Endobronchial Tube in Patients Undergoing One-lung Ventilation

Not Applicable

Completed

Conditions: Intubation Tube(Intubation Using Double Lumen Endobronchial Tube)

Interventions: Device: Endobronchial intubation

First Posted Date: 2018-12-20

Last Posted Date: 2019-05-20

Lead Sponsor: Yonsei University

Target Recruit Count: 190

Registration Number: NCT03782090

Locations: 🇰🇷
Department of Anesthesiology and Pain Medicine, Severance, Seoul, Korea, Republic of

Efficacy of High Flow Nasal Oxygen During Sleep Endoscopy in Patients of Obstructive Sleep Apnea

Not Applicable

Completed

Conditions: Obstructive Sleep Apnea

Interventions: Procedure: High-flow nasal oxygen
Procedure: Low-flow nasal oxygen

First Posted Date: 2018-12-17

Last Posted Date: 2022-07-05

Lead Sponsor: Yonsei University

Target Recruit Count: 24

Registration Number: NCT03777202

Locations: 🇰🇷
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of

Low- and Moderate-intensity Statin and Clinical Outcome of Primary Prevention in Individuals Aged >75 Years: the SCOPE-75 RCT Study

Phase 4

Not yet recruiting

Conditions: Healthy Elderly Individuals With High LDL-cholesterol or Risk of Cardiovascular Disease

Interventions: Drug: Low intensity statin
Drug: Moderate intensity statin

First Posted Date: 2018-12-10

Last Posted Date: 2020-02-06

Lead Sponsor: Yonsei University

Target Recruit Count: 2484

Registration Number: NCT03770312

Locations: 🇰🇷
Division of Cardiology, Cardiovascular Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of

A Trial to Evaluate the Efficacy of Poziotinib, Pan HER Inhibitor in Recurrent/Metastatic Esophageal Cancer (R/M ESCC)

Phase 2

Conditions: Inoperable or Recurrent or Metastatic Esophageal Squamous Carcinoma

Interventions: Drug: Treatment with Poziotinib

First Posted Date: 2018-12-10

Last Posted Date: 2019-02-22

Lead Sponsor: Yonsei University

Target Recruit Count: 49

Registration Number: NCT03770988

Locations: 🇰🇷
Severance Hospital, Seoul, Korea, Republic of

Aspirin Withdrawal and Clinical Outcome in Patients With Moderate to High Cardiovascular Risk But Without Cardiovascular Disease

Not Applicable

Not yet recruiting

Conditions: Healthy Participants With Moderate and High Cardiovascular Risk

Interventions: Other: Withdrawal of aspirin

First Posted Date: 2018-11-28

Last Posted Date: 2019-02-11

Lead Sponsor: Yonsei University

Target Recruit Count: 4118

Registration Number: NCT03757156

Locations: 🇰🇷
Division of Cardiology, Cardiovascular Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of

The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity

Completed

Conditions: Vitiligo

First Posted Date: 2018-11-15

Last Posted Date: 2020-10-19

Lead Sponsor: Yonsei University

Target Recruit Count: 43

Registration Number: NCT03741738

Locations: 🇰🇷
Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of

A Clinical Trial of Silk Peptide for the Evaluation of Efficacy on Immune Function

Not Applicable

Conditions: Normal Healthy Subjects

Interventions: Dietary Supplement: Investigational Product (Silk Peptide)
Dietary Supplement: Control Group - Placebo Product

First Posted Date: 2018-11-14

Last Posted Date: 2018-11-14

Lead Sponsor: Yonsei University

Target Recruit Count: 110

Registration Number: NCT03739970

Locations: 🇰🇷
Laboratory of Clinical Nutrigenetics/Nutrigenomics, Yonsei University., Seoul, Korea, Republic of

Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients.

Phase 2

Active, not recruiting

Conditions: Hypopharynx
Stage II-IVB Operable HNSCC Oral Cavity
Oropharynx
Larynx

Interventions: Drug: durvalumab + tremelimumab
Drug: Durvalumab

First Posted Date: 2018-11-13

Last Posted Date: 2023-03-21

Lead Sponsor: Yonsei University

Target Recruit Count: 48

Registration Number: NCT03737968

Locations: 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy